NCT02985216View on ClinicalTrials.gov

Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

371

Participants

Timeline

Start Date

February 7, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

May 2, 2018

Conditions
Peripheral Neuropathic Pain
Interventions
DRUG

YHD1119

"YHD1119 150mg, PO YHD1119 300mg, PO~YHD1119 600mg, PO"

DRUG

Lyrica

Lyrica 75mg, PO Lyrica 150mg, PO Lyrica 300mg, PO

Trial Locations (1)

Unknown

Yong Chul Kim, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02985216 - Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter